A scoring model for predicting advanced colorectal neoplasia in a screened population of asymptomatic Japanese individuals Masau SekiguchiYasuo KakugawaTakahisa Matsuda Original Article—Alimentary Tract 22 January 2018 Pages: 1109 - 1119
Risk assessment of metachronous squamous cell carcinoma after endoscopic resection for esophageal carcinoma based on the genetic polymorphisms of alcoholdehydrogense-1B aldehyde dehydrogenase-2: temperance reduces the risk Satoshi AbikoYuichi ShimizuNaoya Sakamoto Original Article—Alimentary Tract 08 February 2018 Pages: 1120 - 1130
Induction of PIR-A/B+ DCs in the in vitro inflammatory condition and their immunoregulatory function Fumi MatsuiMuneo InabaKazuichi Okazaki Original Article—Alimentary Tract 05 March 2018 Pages: 1131 - 1141
Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group Keiji TsujiMasayuki KurosakiNamiki Izumi Original Article—Liver, Pancreas, and Biliary Tract 06 April 2018 Pages: 1142 - 1150
Is patient-reported outcome improved by nalfurafine hydrochloride in patients with primary biliary cholangitis and refractory pruritus? A post-marketing, single-arm, prospective study Minami YagiAtsushi TanakaJapan PBC Study Group (JPBCSG) Original Article—Liver, Pancreas, and Biliary Tract 16 April 2018 Pages: 1151 - 1158
Germline variants in pancreatic cancer patients with a personal or family history of cancer fulfilling the revised Bethesda guidelines Akihiro OhmotoChigusa MorizaneTakuji Okusaka Original Article—Liver, Pancreas, and Biliary Tract 17 April 2018 Pages: 1159 - 1167
The “real-world” efficacy and safety of DAAs for the treatment of HCV patients throughout Japan Shinya MaekawaNobuyuki Enomoto Editorial 06 July 2018 Pages: 1168 - 1169
